Calamos Advisors LLC Johnson & Johnson Transaction History

Calamos Advisors LLC

$14.5 Billion
Q1 2024

A detailed history of Calamos Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Calamos Advisors LLC holds 633,078 shares of JNJ stock, worth $92.5 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

633,078

Previous 642,688 1.5%

Holding current value

$92.5 Million

Previous $101 Million 0.58%

% of portfolio

0.69%

Previous 0.72%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$155.22 - $162.74 $1.49 Million - $1.56 Million	-9,610 Reduced 1.5%	633,078 $100 Million
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $559,540 - $610,575	-3,843 Reduced 0.59%	642,688 $101 Million
Q3 2023 Oct 25, 2023	SELL	$155.75 - $174.48 $7.85 Million - $8.8 Million	-50,433 Reduced 7.24%	646,531 $101 Million
Q2 2023 Jul 28, 2023	BUY	$154.35 - $166.11 $102,951 - $110,795	667 Added 0.1%	696,964 $115 Million
Q1 2023 May 03, 2023	SELL	$151.05 - $180.26 $8.27 Million - $9.87 Million	-54,747 Reduced 7.29%	696,297 $108 Million

Q4 2022 Jan 25, 2023	SELL	$160.2 - $179.79 $13.9 Million - $15.6 Million	-86,758 Reduced 10.36%	751,044 $0
Q3 2022 Oct 24, 2022	BUY	$161.33 - $179.52 $68,565 - $76,296	425 Added 0.05%	837,802 $137 Million
Q2 2022 Aug 01, 2022	BUY	$168.19 - $186.01 $8.56 Million - $9.47 Million	50,899 Added 6.47%	837,377 $149 Million
Q1 2022 May 03, 2022	BUY	$158.14 - $179.59 $18.4 Million - $20.9 Million	116,269 Added 17.35%	786,478 $139 Million
Q4 2021 Feb 01, 2022	SELL	$155.93 - $173.01 $9.49 Million - $10.5 Million	-60,871 Reduced 8.33%	670,209 $115 Million
Q3 2021 Oct 26, 2021	BUY	$161.5 - $179.47 $7.9 Million - $8.78 Million	48,943 Added 7.17%	731,080 $118 Million
Q2 2021 Jul 22, 2021	BUY	$159.48 - $171.07 $18.3 Million - $19.6 Million	114,852 Added 20.25%	682,137 $112 Million
Q1 2021 Apr 12, 2021	BUY	$153.07 - $170.48 $1.84 Million - $2.05 Million	12,031 Added 2.17%	567,285 $93.2 Million
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $2.3 Million - $2.64 Million	-16,747 Reduced 2.93%	555,254 $87.4 Million
Q3 2020 Oct 26, 2020	SELL	$140.38 - $153.83 $4.86 Million - $5.33 Million	-34,641 Reduced 5.71%	572,001 $85.2 Million
Q2 2020 Jul 27, 2020	SELL	$128.81 - $155.51 $3.56 Million - $4.3 Million	-27,632 Reduced 4.36%	606,642 $85.3 Million
Q1 2020 Apr 28, 2020	SELL	$111.14 - $153.99 $69.4 Million - $96.2 Million	-624,480 Reduced 49.61%	634,274 $83.2 Million
Q4 2019 Jan 15, 2020	BUY	$127.5 - $146.44 $6.13 Million - $7.04 Million	48,041 Added 3.97%	1,258,754 $184 Million
Q3 2019 Oct 21, 2019	SELL	$126.95 - $142.14 $14.7 Million - $16.4 Million	-115,574 Reduced 8.71%	1,210,713 $157 Million
Q2 2019 Aug 07, 2019	SELL	$131.15 - $144.24 $18.3 Million - $20.1 Million	-139,369 Reduced 9.51%	1,326,287 $185 Million
Q1 2019 Apr 12, 2019	SELL	$125.72 - $139.79 $15.7 Million - $17.5 Million	-125,236 Reduced 7.87%	1,465,656 $205 Million
Q4 2018 Jan 24, 2019	SELL	$122.84 - $147.84 $15.3 Million - $18.4 Million	-124,315 Reduced 7.25%	1,590,892 $205 Million
Q3 2018 Oct 22, 2018	BUY	$121.58 - $142.88 $12.2 Million - $14.3 Million	99,970 Added 6.19%	1,715,207 $237 Million
Q2 2018 Jul 17, 2018	BUY	$119.4 - $131.76 $7.73 Million - $8.53 Million	64,712 Added 4.17%	1,615,237 $196 Million
Q1 2018 Apr 13, 2018	BUY	$125.1 - $148.14 $14.4 Million - $17 Million	114,913 Added 8.0%	1,550,525 $199 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $1.5 Million - $1.65 Million	-11,460 Reduced 0.79%	1,435,612 $201 Million
Q3 2017 Oct 25, 2017	BUY	$129.47 - $135.38 $34.4 Million - $36 Million	266,023 Added 22.52%	1,447,072 $188 Million
Q2 2017 Aug 09, 2017	BUY	N/A	1,181,049	1,181,049 $156 Million

Others Institutions Holding JNJ

# of Institutions

4,145

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Johnson & Johnson Transaction History